Thursday, December 19, 2024
HomeTagsPsychiatric disorders

psychiatric disorders

AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders

AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics